In Vivo Validation Services

This subcontract for In Vivo Validation Services supports NIH National Cancer Institute projects by providing biological validation of technology using vertebrate animal models. The scope of work includes conducting in vivo studies, animal handling, dosing, and monitoring biological responses, culminating in a validation report featuring quantitative performance data. To ensure compliance with NIH Section 8.7, the provider must utilize AAALAC-accredited animal facilities and obtain all necessary IACUC approvals. The opportunity is a total small business set-aside under NAICS code 541715, specifically targeting firms with fewer than 500 employees in accordance with SBIR/STTR mandates. Interested parties must submit their responses by September 21, 2026, for this Department of Health and Human Services initiative.